Champagne au Mont d'Or, France

Anne-Sophie Rebstock

USPTO Granted Patents = 27 

 

Average Co-Inventor Count = 9.6

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Lyons, FR (2014 - 2017)
  • Wuppertal, DE (2016 - 2017)
  • Champagne au Mont d'Or, FR (2019 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Anne-Sophie Rebstock

Introduction:

Anne-Sophie Rebstock, a prolific inventor hailing from Champagne au Mont d'Or, France, has left a remarkable footprint in the world of patents with a total of 25 patents to his name. His cutting-edge work in the field of prodrugs and their application in the treatment and prevention of diseases, especially cancers, has garnered widespread recognition.

Latest Patents:

Rebstock's latest patents showcase his expertise in developing prodrugs of cytotoxic active agents with enzymatically cleavable groups. These prodrugs utilize innovative structures to enable the targeted release of cytotoxic drugs by tumour-associated proteases. The reduction of legumain-cleavable substrate peptide sequences to an asparagine derivative as a structural motif not only increases stability in healthy organs' lysosomes but also enhances the anti-tumor effect significantly.

Career Highlights:

Having contributed significantly to the advancements in pharmacology, Anne-Sophie Rebstock has worked with renowned companies such as Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. His dedication to innovation and relentless pursuit of developing novel treatment methods for hyperproliferative and angiogenic disorders have solidified his reputation as a visionary in the field.

Collaborations:

Throughout his career, Rebstock has collaborated with esteemed professionals such as Hans-Georg Lerchen and Beatrix Stelte-Ludwig. These collaborations have led to groundbreaking inventions and paved the way for the development of innovative medicaments to combat various diseases, particularly cancer.

Conclusion:

Inventor Anne-Sophie Rebstock's pioneering work in the realm of prodrugs and his commitment to revolutionizing the treatment of diseases stand as a testament to his unwavering dedication to innovation. His patents not only showcase his ingenuity but also represent a beacon of hope for individuals battling hyperproliferative and angiogenic disorders worldwide. Anne-Sophie Rebstock's contributions have undoubtedly left an indelible mark on the field of pharmacology, setting new standards for future generations of inventors to follow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…